Roche Sues Pfizer to Bar Biosimilar of Cancer Drug Herceptin
Roche Holding AG, facing pressure in Europe as cheaper biosimilars of its three biggest cancer medicines chew away at its revenue, sued to block Pfizer Inc. from selling a copy of its breast-cancer drug ...